ACM
ADAR1 Capital Management Portfolio holdings
AUM
$1.01B
1-Year Est. Return
174.02%
1 Year Est. Return
+174.02%
AUM
$1.01B
AUM Growth
+$394M
(+64%)
Holding
251
Top Buys
| 1 | +$27.5M | |
| 2 | +$21.3M | |
| 3 | +$21.3M | |
| 4 |
ETNB
89bio
ETNB
|
+$18.2M |
| 5 |
Lexeo Therapeutics
LXEO
|
+$9.21M |
Top Sells
| 1 | +$146M | |
| 2 | +$18.6M | |
| 3 | +$11M | |
| 4 |
Mineralys Therapeutics
MLYS
|
+$8.49M |
| 5 |
RAPT Therapeutics
RAPT
|
+$7.1M |
Sector Composition
| 1 | Healthcare | 87.56% |
| 2 | Financials | 1.74% |
| 3 | Consumer Discretionary | 0.24% |
| 4 | Communication Services | 0.1% |
| 5 | Technology | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Nektar Therapeutics
NKTR
$1.24B
| $4.1M | 0.38% |
72,007
+56,211
|
|
||
52
Establishment Labs
ESTA
$1.97B
| $3.72M | 0.35% |
90,688
+65,688
|
|
||
53
Sanofi
SNY
$121B
| $3.5M | 0.33% |
74,212
+64,212
|
|
||
54
Krystal Biotech
KRYS
$6.24B
| $3.27M | 0.31% |
+18,523
|
|
||
55
NewAmsterdam Pharma
NAMS
$4.49B
| $3.25M | 0.31% |
114,359
+2,000
|
|
||
56
Fulcrum Therapeutics
FULC
$534M
| $3.14M | 0.3% |
341,612
+288,263
|
|
||
57
Merus
MRUS
$7.28B
| $3.14M | 0.29% |
33,313
+15,000
|
|
||
|
58
Mineralys Therapeutics
MLYS
$3.22B
| $2.97M | 0.28% |
78,238
-223,887
|
|
||
59
Kiniksa Pharmaceuticals
KNSA
$3.1B
| $2.92M | 0.27% |
75,187
+18,647
|
|
||
60
Celldex Therapeutics
CLDX
$1.72B
| $2.83M | 0.27% |
109,442
+51,976
|
|
||
61
Zura Bio
ZURA
$242M
| $2.82M | 0.27% |
652,154
-345,393
|
|
||
62
Vertex Pharmaceuticals
VRTX
$108B
| $2.74M | 0.26% |
+7,000
|
|
||
63
Arcellx
ACLX
$4.06B
| $2.58M | 0.24% |
31,484
+17,522
|
|
||
64
Biogen
BIIB
$26.1B
| $2.52M | 0.24% |
18,000
+12,900
|
|
||
65
Delcath Systems
DCTH
$338M
| $2.41M | 0.23% |
224,385
+75,000
|
|
||
66
Avidity Biosciences
RNA
$10.8B
| $2.34M | 0.22% |
+53,656
|
|
||
67
Madrigal Pharmaceuticals
MDGL
$13.2B
| $2.25M | 0.21% |
4,895
+3,841
|
|
||
|
ASPC
68
A SPAC III Acquisition Corp
ASPC
$24.6M
| $2.22M | 0.21% |
215,000
|
|
||
69
Masimo
MASI
$7.74B
| $2.21M | 0.21% |
+15,000
|
|
||
70
Viridian Therapeutics
VRDN
$3B
| $2.19M | 0.21% |
101,704
-68,894
|
|
||
71
Summit Therapeutics
SMMT
$12.8B
| $2.13M | 0.2% |
102,969
+90,969
|
|
||
72
Cidara Therapeutics
CDTX
$6.91B
| $2.06M | 0.19% |
21,522
|
|
||
73
Regenxbio
RGNX
$638M
| $1.98M | 0.19% |
205,409
-2,409
|
|
||
74
Korro Bio
KRRO
$50.7M
| $1.93M | 0.18% |
40,235
-28,580
|
|
||
75
Rocket Pharmaceuticals
RCKT
$342M
| $1.88M | 0.18% |
575,800
+300,000
|
|